Document Detail


Correlation of in vivo and in vitro inhibition of thrombin by plasma inhibitors.
MedLine Citation:
PMID:  429864     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Rabbit antithrombin III and thrombin were purified to homogeneity to determine the in vivo relationship of these proteins in an autologous system. These proteins, radiolabeled with Na[125I], were injected into rabbits to determine the circulatory half-life. The mean half-life values were 125I-antithrombin III, 54.75 +/- 3.10 hr; 125I-thrombin, 7.25 +/- 1.49 hr; 125I-thrombin-antithrombin III, 7.25 +/- 1.09 hr; 125I[thrombin-antithrombin III], 11.13 +/- 0.88 hr; and Tos-Lys-CH2Cl-125I-thrombin, 27.75 +/- 3.18 hr. All the mean half-life values were statistically different from that of thrombin alone except for the two forms of thrombin-antithrombin III complex. Following injection of the radiolabeled proteins, plasma samples were obtained and gel-filtered to analyze the molecular weight distribution of the radiolabel. An identical elution position on gel filtration of 125I-antithrombin III with native antithrombin III was observed. The 125I-thrombin distributed into two peaks of radioactivity, with a molecular weight of 100,000 (79%) and a molecular weight greater than 200,000 (21%). The 100,000 dalton peak is consistent with a thrombin--antithrombin III complex, and the greater than 200,000 dalton peak is consistent with a thrombin-alpha 2-macroglobulin complex as confirmed by in vitro immunochemical studies. Thrombin inactivated with Tos-Lys-CH2Cl also showed two peaks of radioactivity on gel filtration, one peak which was excluded from the column and the other peak with an elution volume that was consistent with the position of native thrombin.
Authors:
C N Vogel; H S Kingdon; R L Lundblad
Related Documents :
23733564 - An antibody-free strategy for screening putative hdm2 inhibitors using crude bacterial ...
12223464 - The ins and outs of apc and beta-catenin nuclear transport.
23480844 - Recent applications of isotopic labeling for protein nmr in drug discovery.
23611424 - A hybrid-soft solar cell based on the mycobacterial porin mspa linked to a sensitizer-v...
23283414 - Interplay between native topology and non-native interactions in the folding of tethere...
6990654 - Utilization of waste products of dehydrated onion industry for production of fodder yea...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The Journal of laboratory and clinical medicine     Volume:  93     ISSN:  0022-2143     ISO Abbreviation:  J. Lab. Clin. Med.     Publication Date:  1979 Apr 
Date Detail:
Created Date:  1979-06-26     Completed Date:  1979-06-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375375     Medline TA:  J Lab Clin Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  661-73     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antithrombin III
Binding Sites
Protease Inhibitors / blood*
Thrombin / antagonists & inhibitors*
Chemical
Reg. No./Substance:
0/Protease Inhibitors; 9000-94-6/Antithrombin III; EC 3.4.21.5/Thrombin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Platelet membrane glycoproteins in thrombasthenia, Bernard-Soulier syndrome, and storage pool diseas...
Next Document:  Sulfhydryl-mediated depression of ciliary activity: an adverse effect of acetylcysteine.